| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |